JCI vs JUNS · P/E 44, rev $23.60B vs rev $21.8K
Johnson Controls International PLC (JCI) versus Jupiter Neurosciences, Inc. Common Stock (JUNS) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. JUNS currently screens at market cap $10.0M.
Not investment advice. Open the JCI and JUNS stock pages for the full models.
Not investment advice.